• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2011

View Archived Issues

Encouraging phase I data presented on GDC-0068 and GDC-0941 in cancer

Read More

Cixutumumab monotherapy is not beneficial in phase II hepatocellular carcinoma trial

Read More

Preliminary first-in-human results indicate ATU-027 RNAi therapy is well tolerated

Read More

New modulators of lysophospholipid S1P1 receptor presented

Read More

Phase III trial evaluates linagliptin/metformin combination in type 2 diabetes

Read More

Boehringer Ingelheim discloses new ribosomal protein S6 kinase alpha-3 inhibitors

Read More

Galderma presents novel peroxide derivatives for acne

Read More

CNX-011-67 improves responsiveness to glucose in models of diabetes

Read More

BioAlliance Pharma submits application to French Drug Agency for phase III Livatag trial

Read More

Phase I trial assesses TPI-287 with and without temozolomide in neuroblastoma/medulloblastoma

Read More

EpiCept receives initial responses from FDA regarding SPA application for Ceplene in AML

Read More

Living Cell Technologies begins enrollment in phase II Diabecell trial

Read More

Scientists at Sanofi design new pim kinase inhibitors for cancer

Read More

Dosing begins in phase I trial of antisense therapy ATL-1103

Read More

Japanese MAA submitted for Eylea for wet AMD

Read More

Medivir patents new cathepsin S inhibitors

Read More

Cardium Therapeutics to acquire Transdel Pharmaceuticals

Read More

FDA grants orphan drug status to anticancer product MDX-1097

Read More

Cynapsus provides update on oral apomorphine for Parkinson's disease

Read More

CHMP recommends approval of Eurartesim for malaria

Read More

Enrollment complete in phase III MOTION trial of safinamide in early Parkinson's disease

Read More

Health Canada approves Tasigna for newly diagnosed Ph+ CML

Read More

FDA accepts for review Pfizer's application for axitinib in advanced renal cell carcinoma

Read More

Progenics submits sNDA for Relistor for OIC in patients with chronic noncancer pain

Read More

Phase I/II trial of 2B3-101 to begin in patients with brain metastases

Read More

Torrent Pharmaceuticals' new HSP70 inducer TRC-051384 reduces symptoms of stroke in vivo

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe